Xspray Pharma has now completed the population pharmacokinetic (PopPK) modeling that constitutes key regulatory documentation ...

STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor ...

STOCKHOLM, SE / ACCESS Newswire / June 30, 2025 / Vicore Pharma Holding AB (publ) (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agoni ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

In the course of the public share buyback offer by Medios AG announced on June 18, 2025, a total of 1,077,813 shares were tendered by the end of the acceptance period. The offer was made for up to ...

StudyFormycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206 10.07.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

CVC has secured total stake of 27.78% of the share capital and voting rights in CompuGroup Medical; founding family Gotthardt retains majority stake of 50.12% CVC as second anchor shareholder will ...

OSLO, Norway I June 30, 2025 I BerGenBio ASA (OSE: BGBIO) ("BerGenBio" or the "Company") and Oncoinvent ASA (OSE: ONCIN) ("Oncoinvent") announce that they ...

Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to resolve thousands of opioid lawsuits against the drugmaker and its ...

Innate Pharma SA today announced that members of its executive team will participate in the upcoming investor conferences, detailed below. Innate Pharma is a trusted partner to biopharmaceutical ...